Roberta Di Fonte

Bari, 70124, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Unraveling vascular mechanisms in melanoma: roles of angiogenesis and vasculogenic mimicry in tumor progression and therapeutic resistance.

Unraveling vascular mechanisms in melanoma: roles of angiogenesis and vasculogenic mimicry in tumor progression and therapeutic resistance.

Journal: Cancer biology & medicine

Published: November 18, 2025

Nanoparticle based siRNA therapeutics for ovarian cancer overcoming drug resistance and future directions.

Nanoparticle based siRNA therapeutics for ovarian cancer overcoming drug resistance and future directions.

Journal: Discover nano

Published: October 17, 2025

Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma.

Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma.

Journal: Clinical immunology (Orlando, Fla.)

Published: September 29, 2025

Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma.

Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6+ and S100A8+ myeloid subsets in pancreatic ductal adenocarcinoma.

Journal: Clinical immunology (Orlando, Fla.)

Published: September 29, 2025

LncRNA expression in prostate cancer: From in silico analysis to urinary EV-based liquid biopsy for prognosis.

LncRNA expression in prostate cancer: From in silico analysis to urinary EV-based liquid biopsy for prognosis.

Journal: Non-coding RNA research

Published: July 04, 2025

Irisin and Metastatic Melanoma: Selective Anti-Invasiveness Activity in BRAF Wild-Type Cells.

Irisin and Metastatic Melanoma: Selective Anti-Invasiveness Activity in BRAF Wild-Type Cells.

Journal: International journal of molecular sciences

Published: December 18, 2024

Developing a risk score using liquid biopsy biomarkers for selecting Immunotherapy responders and stratifying disease progression risk in metastatic melanoma patients.

Developing a risk score using liquid biopsy biomarkers for selecting Immunotherapy responders and stratifying disease progression risk in metastatic melanoma patients.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 04, 2024

Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells.

Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells.

Journal: International journal of nanomedicine

Published: August 02, 2024

Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy?

Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy?

Journal: Biomolecules

Published: February 07, 2024

Microfluidic development and biological evaluation of targeted therapy-loaded biomimetic nano system to improve the metastatic melanoma treatment.

Microfluidic development and biological evaluation of targeted therapy-loaded biomimetic nano system to improve the metastatic melanoma treatment.

Journal: International journal of pharmaceutics

Published: September 01, 2023

Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.

Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 16, 2023

Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids.

Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids.

Journal: Frontiers in cell and developmental biology

Published: March 02, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026